World's Best Scientists 2026 revealed!
Hans-Jörg Bühring

Hans-Jörg Bühring

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
24028
World Ranking
4731
National Ranking
348

Overview

Hans-Jörg Bühring is affiliated with the University of Tübingen in Germany and has contributed research primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work covers several focused areas of study including Immunology, Molecular Biology, Oncology, Hematology, and Genetics.

The scientist's research topics include:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Acute Myeloid Leukemia Research
  • Immunotherapy and Immune Responses
  • RNA Interference and Gene Delivery
  • Viral Infectious Diseases and Gene Expression in Insects
  • Lymphoma Diagnosis and Treatment

Frequent publication venues for their work are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Frontiers in Molecular Medicine
  • Journal for ImmunoTherapy of Cancer
  • Scientific Reports

Hans-Jörg Bühring has collaborated often with the following coauthors:

  • Anudishi Tyagi
  • Stanley Ly
  • Fouad El-Dana
  • Sabrina Grimm
  • Appalaraju Jaggupilli

Recent publications illustrate the scope and focus of their research:

  • "A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL," 2022, Journal for ImmunoTherapy of Cancer
  • "Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML," 2022, Blood
  • "The osteogenic commitment of CD271+CD56+ bone marrow stromal cells (BMSCs) in osteoarthritic femoral head bone," 2020, Scientific Reports
  • "Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors," 2023, Frontiers in Molecular Medicine
  • "Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia," 2020, EBioMedicine

Collectively, this body of work aligns with ongoing efforts to understand and develop immunotherapies, particularly in hematologic malignancies like acute myeloid leukemia (AML) and B-cell acute lymphoblastic leukemia (B-ALL). The focus on cellular immunology and molecular pathways highlights a translational approach integrating laboratory research with clinical relevance.

Best Publications

  • A perivascular origin for mesenchymal stem cells in multiple human organs

    Mihaela Crisan;Solomon Veloso Yap;Louis Casteilla;Louis Casteilla;Chien-Wen Chen

  • Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.

    Ornella Parolini;Francesco Alviano;Gian Paolo Bagnara;Grozdana Bilic

  • Retraction: Generation of pluripotent stem cells from adult human testis

    Sabine Conrad;Markus Renninger;Jörg Hennenlotter;Tina Wiesner

  • Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres

    Steffen Walter;Leah Herrgen;Oliver Schoor;Gundram Jung

  • Flk-1 expression defines a population of early embryonic hematopoietic precursors

    N. Kabrun;H.J. Buhring;K. Choi;A. Ullrich

  • Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1

    Venkata Lokesh Battula;Sabrina Treml;Petra M. Bareiss;Friederike Gieseke

  • Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.

    Martina Seiffert;Charles Cant;Charles Cant;Charles Cant;Zhengjun Chen;Zhengjun Chen;Zhengjun Chen;Irene Rappold;Irene Rappold;Irene Rappold

  • Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.

    Venkata Lokesh Battula;Petra M. Bareiss;Sabrina Treml;Sabine Conrad

  • Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells

    Wichard Vogel;Frank Grünebach;Conrad A Messam;Lothar Kanz

  • MICA/NKG2D-Mediated Immunogene Therapy of Experimental Gliomas

    Manuel A. Friese;Michael Platten;Stefan Z. Lutz;Ulrike Naumann

  • A novel marker of human endometrial mesenchymal stem-like cells.

    Hirotaka Masuda;Siti Shahera Anwar;Hans-jorg Buhring;Jyothsna Rama Rao

  • The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis.

    Hans-Jörg Bühring;Anna Streble;Peter Valent

  • The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

    Peter Brossart;Anya Schneider;Patricia Dill;Theodora Schammann

  • Biology and plasticity of CD133+ hematopoietic stem cells.

    Rupert Handgretinger;Paul R. Gordon;Thasia Leimig;Xiaohua Chen

  • The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.

    H J Bühring;P J Simmons;M Pudney;R Müller

  • Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts.

    Anne Gougos;Sylvie St Jacques;Adonna Greaves;Philip J. O'Connell

  • Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology

    Alwin Scharstuhl;Bernhard Schewe;Karin Benz;Christoph Gaissmaier

  • Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.

    Alexander W. Hauswirth;Susanne Natter;Minoo Ghannadan;Yasamin Majlesi

  • Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes

    Armin Saalmüller;Matthias J. Reddehase;Hans-Jörg Bühring;Stipan Jonjić

  • Signal Regulatory Protein (SIRPα), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration

    Yuan Liu;Hans-Jörg Bühring;Ke Zen;Stephanie L. Burst

Frequent Co-Authors

Lothar Kanz
Lothar Kanz University of Tübingen
Peter Valent
Peter Valent Medical University of Vienna
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Graham Pawelec
Graham Pawelec University of Tübingen
Arnulf Stenzl
Arnulf Stenzl University of Tübingen
Axel Ullrich
Axel Ullrich Max Planck Institute of Biochemistry
Wolfgang R. Sperr
Wolfgang R. Sperr Medical University of Vienna
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Frank Grünebach
Frank Grünebach University of Tübingen
Claudia A. Müller
Claudia A. Müller University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Hans-Jörg Bühring

Trending Scientists

Recently Published Articles